Breaking News
Get 45% Off 0
💰 With a 129% YTD gain in the bag, these are our AI’s top global picks for March
Read now

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Factors Setting The Tone For Signet (SIG) In Q3 Earnings By Zacks Investment Research - Nov 15, 2017

Signet Jewelers Limited (NYSE:SIG) , a retailer of diamond jewelry, watches and other products, is slated to report third-quarter fiscal 2018 results on Nov 21. Last quarter, the company’s...

Zacks Investment Research
5 ETF Areas Hitting Highs On Market Dip By Zacks Investment Research - Nov 15, 2017

Wall Street stepped back on Nov 14, after the industrial conglomerate giant, General Electric (NYSE:GE) maintained its steep southward journey. The stock has been suffering due to a dividend cut and...

Zacks Investment Research
Avoid XL Group (XL), Add These 3 Insurance Stocks Instead By Zacks Investment Research - Nov 15, 2017

XL Group Ltd (NYSE:XL) has been witnessing downward revisions over the last 30 days. The Zacks Consensus Estimate of a loss of $1.41 for 2017 is worse than the loss of $1.11 per share, expected 30...

Zacks Investment Research
Facebook Hints At Russia Interference In Brexit By Zacks Investment Research - Nov 15, 2017

Facebook Inc’s (NASDAQ:FB) Russia woes seem to be never ending. Per a BuzzFeed report, Facebook said that Russia may have tried to meddle (though the extent is not known to be significant)...

Tim Knight
BAP Tumbling Away By Tim Knight - Nov 15, 2017

Good morning, everyone – – just a quick chart to start the day: Credicorp Ltd (NYSE:BAP) has a very long pattern, and its resistance line goes back for years. We’ve got close to it...

Zacks Investment Research
J&J Presents Positive New Data For Diabetes Drug Invokana By Zacks Investment Research - Nov 15, 2017

Johnson & Johnson (NYSE:JNJ) presented new data from a large CANVAS outcomes program on its type II diabetes drug, Invokana (SGLT2 inhibitor), demonstrating an improved renal outcome. The data...

Zacks Investment Research
Should You Own Applied Materials (AMAT) Ahead Of Earnings?   By Zacks Investment Research - Nov 15, 2017

On Thursday, November 16th, Applied Materials (NASDAQ:AMAT) will release its fourth quarter earnings results fter the bell. The company is a Zacks Rank 2 (Buy), and have a Value, Growth, and Momentum...

Zacks Investment Research
GE Still Going Downhill: Dump Or Buy On The Cheap? By Zacks Investment Research - Nov 15, 2017

Shares of industrial goods manufacturer General Electric Company (NYSE:GE) continued to fall for the second consecutive day on massive dividend cut and radical business restructuring policies made...

Ticker.tv News
Advanced Auto Parts Shares Rally Following Q3 Profit Beat By Ticker.tv News - Nov 15, 2017

Advance Auto Parts Inc (NYSE:AAP) On Tuesday before the market opened, Advanced Auto Parts ($AAP) announced third quarter earnings that topped analyst estimates and sent shares rallying in the...

Zacks Investment Research
Time Gains As Sports Illustrated Streaming Platform Debuts By Zacks Investment Research - Nov 15, 2017

Shares Time Inc. (NYSE:TIME) rose on Wednesday following the news that it is set to debut a new Sports Illustrated video streaming service on Amazon (NASDAQ:AMZN) .Sports Illustrated TV will make...

Keith Fitz-Gerald
SNAP: Still The Most Dangerous IPO I've Ever Seen By Keith Fitz-Gerald - Nov 15, 2017

Last November I called Snap Inc (NYSE:SNAP) the "single most dangerous" IPO I'd ever seen and urged you to give the company a wide berth… or take your money to Las Vegas where at least you'd...

Jani Ziedins
What To Expect For S&P 500 Over The Near-Term By Jani Ziedins - Nov 15, 2017

End of Day Update: On Tuesday the S&P 500 stumbled for the fourth time out of the last six sessions. In mid-morning trade the index undercut 2,570, but selling stalled and prices rebounded shortly...

Zacks Investment Research
ExxonMobil Can Make You Rich, Not Chevron: Here's Why By Zacks Investment Research - Nov 15, 2017

Among the major integrated energy firms, ExxonMobil Corporation (NYSE:XOM) and Chevron Corporation (NYSE:CVX) deserve a special mention, since they have such massive market caps of $351.4 billion...

Zacks Investment Research
Valeant (VRX) Announces Pricing Of Senior Secured Notes By Zacks Investment Research - Nov 15, 2017

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that it has priced its previously announced offering of $750,000,000 aggregate principal amount of 5.500% senior secured notes due...

Continue with Apple
Continue with Google
or
Sign up with Email